-
Kohli fires Bengaluru to big win after IPL remembers stampede dead
-
Graou shines as Toulouse sink Montpellier, Pau climb to second in Top 14
-
Vingegaard nears Tour of Catalonia victory with stage six win
-
Malinin bounces back from Olympic meltdown with third straight world skating gold
-
French police foil Paris bomb attack outside US bank
-
Senegal parade AFCON trophy at Stade de France, despite being stripped of title
-
Graou shines as Toulouse sink Montpellier to extend Top 14 lead
-
Anti-Trump protests launch on 'No Kings' day in US
-
Protesters rally in London against UK far-right rise
-
France foils Paris bomb attack outside US bank
-
Indian Premier League cricket season begins with silence to honour stampede dead
-
Missing Cuba-bound aid boats located, crew reported safe
-
Ignore our celebrations, we respect Bosnian team, says Italy's Dimarco
-
Case closed for Morocco despite Senegal Afcon outrage
-
22 migrants die off Greece after six days at sea: survivors
-
Henderson backs England's White after Wembley boos
-
Zelensky visits UAE, Qatar for air security talks with Gulf
-
Hollingsworth upsets Hunter Bell as Gout Gout fails to fire in Melbourne
-
Iran footballers pay tribute to victims of school strike
-
Questions over Israel's interceptor stockpiles as Mideast war drags on
-
Sweet heist? Nestle says 12 tonnes of KitKat stolen
-
Pope denounces widening gap between the rich and poor on Monaco visit
-
Yemen's Houthi enter war with missile targeting Israel
-
USS Gerald Ford arrives in Croatia for maintenance
-
Antonelli leads Mercedes 1-2 as Verstappen suffers qualifying shock
-
Verstappen calls his Red Bull 'undriveable' after more woes
-
Antonelli takes pole for Japanese Grand Prix in Mercedes 1-2
-
Millions angry with Trump expected to fill American streets
-
Attacks across Middle East as Iran war enters second month
-
Late surge lifts Thunder, Celtics rally to down Hawks
-
Tiger Woods arrested, charged with DUI after Florida crash
-
Antonelli leads Mercedes one-two in final Japan practice
-
Unease for Iranian-Canadians after shooting at ayatollah critic's gym
-
Sequins, slogans, conspiracies: Inside the right-wing culture at CPAC
-
NBA fines T-Wolves center Reid $50,000 for ripping refs
-
Sinner ousts Zverev to book Miami Open final with Lehecka
-
McKellar hails 'special memory' after Waratahs stun Brumbies
-
Tuchel takes positives from scrappy England draw against Uruguay
-
Japanese star Sakamoto signs off with fourth world skating gold
-
Tuchel disappointed after England fans boo White
-
US envoy hopeful on Iran talks as strikes target nuclear facilities
-
Controversial African champions Morocco salvage Ecuador draw on Ouahbi debut
-
Dutch end Norway's unbeaten run as Haaland rests
-
'Strait of Trump': US president says Iran must open key waterway
-
Wirtz steals show as Germany win thriller in Switzerland
-
White jeered on England return as Uruguay snatch friendly draw
-
Tiger Woods arrested, charged with DUI after Florida crash: police
-
Oyarzabal double fires Spain to win over Serbia
-
More to IOC gender testing than appeasing Trump: ex-IOC executive
-
Japan's Sakamoto ends career with fourth world skating title
Brazilian ritual root gets second life as potential anti-depressant
Long used in Indigenous Brazilian rituals, the jurema preta plant, which contains a potent psychedelic, is gaining ground as a potential treatment for depression.
At street stalls where medicinal herbs are sold, customers can buy the plant's root which contains dimethyltryptamine (DMT), a hallucinogenic substance that researchers say could be used to alleviate symptoms.
Following instructions he found on the internet, Guaracy Carvajal extracted DMT at home in 2016 from roots he bought on the street.
The 31-year-old software programmer, who had tried various treatment for chronic depression he has suffered since adolescence, said the drug makes it "feel like you've solved something in your life."
Physicist Draulio Araujo, who has conducted extensive research on the drug, said "the response is rapid. One day after treatment, (patients) already showed a significant improvement in their depression symptoms."
Yet he also warned that it "is not a magic cure" and that psychedelics "are not for everyone."
As a researcher at the Brain Institute of the Federal University of Rio Grande do Norte, Araujo and his team treated 14 people with the drug for six months.
The patients inhaled vaporized DMT, under medical supervision.
"It's common for our patients to say that something changed, that a key opened something," he said.
His patients also received psychological therapy, and some continued with conventional pharmaceutical drugs.
Neuroscientist Fernanda Palhano-Fontes, also of the Brain Institute, said "we have patients who improve significantly, others who don't improve at all."
Araujo's findings were published in the scientific journal Nature in April. In 2024, he published another study with promising results in the journal Psychedelic Medicine.
As for Carvajal, who stopped using jurema preta some time ago, he said the drug really allows a person to "start to have a lighter life."
It helped him get through a time when he was in "a state of questioning myself" about "work, day-to-day life," he said.
- Spiritual channels -
Brazil occupies a fairly prominent place in DMT research due to the substance's prominence in society, Araujo said.
While there is no ban on the cultivation or possession of jurema, which is also known as Mimosa tenuiflora, consumption of DMT is prohibited, except for religious and scientific use.
Jurema's roots are combined with other plants in a wine-like beverage that is consumed at rituals that include dancing and drums, part of Indigenous tradition in northeast Brazil where the plant grows.
"It's not hallucination," said Joyce Souza, a young woman attending a jurema ceremony in Planaltina, on the outskirts of Brasília.
"My spiritual channels become more accessible, I can communicate better with myself," Souza said.
Gathered in a house courtyard and dressed in white, the group of mostly novices waited for more seasoned practitioners to enter a trance and bring messages from ancient spirits.
Meanwhile, back in the lab, Araujo is hoping to expand his DMT research to a study of 100 patents.
"Let's say that in five years we'll have... a clear picture on when it will reach a real clinical setting," he said.
Ferreira--PC